Suzhou Basecare Medical Corporation Limited Stock
Equities
2170
CNE100004BC1
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 HKD | -2.31% | -9.83% | -10.21% |
Sales 2024 * | 262M 36.17M 282M | Sales 2025 * | 318M 43.9M 343M | Capitalization | 535M 73.9M 577M |
---|---|---|---|---|---|
Net income 2024 * | -160M -22.09M -173M | Net income 2025 * | -117M -16.15M -126M | EV / Sales 2024 * | 2.04 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
-3.32
x | P/E ratio 2025 * |
-4.55
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.54% |
1 day | -2.31% | ||
1 week | -9.83% | ||
Current month | -0.94% | ||
1 month | +4.98% | ||
3 months | +2.43% | ||
6 months | -20.68% | ||
Current year | -10.21% |
Managers | Title | Age | Since |
---|---|---|---|
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Le Jun Yin
DFI | Director of Finance/CFO | 39 | 22-11-27 |
Mao She Rui
COO | Chief Operating Officer | 36 | 14-11-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Xiong Kang
BRD | Director/Board Member | 72 | 21-01-15 |
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Ling Yin Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 11-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 2.11 | -2.31% | 69,500 |
24-05-27 | 2.16 | +5.37% | 71,000 |
24-05-24 | 2.05 | -2.84% | 88,500 |
24-05-23 | 2.11 | -3.65% | 82,500 |
24-05-22 | 2.19 | +5.29% | 389,500 |
Delayed Quote Hong Kong S.E., May 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.21% | 75.67M | |
-24.63% | 7.83B | |
+70.87% | 4.32B | |
+1.53% | 2.63B | |
-7.18% | 2.53B | |
-44.62% | 2.29B | |
-12.67% | 1.82B | |
-19.62% | 1.51B | |
+18.85% | 1.22B | |
-43.60% | 1.17B |
- Stock Market
- Equities
- 2170 Stock